Word: arenal
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...Moniz is also the Director of MIT's Energy Initiative, called MITEI. And he and President Hockfield just showed me some of the extraordinary energy research being conducted at this institute: windows that generate electricity by directing light to solar cells; light-weight, high-power batteries that aren't built, but are grown -- that was neat stuff; engineering viruses to create -- to create batteries; more efficient lighting systems that rely on nanotechnology; innovative engineering that will make it possible for offshore wind power plants to deliver electricity even when the air is still...
...back. It's been stuck in an awful recession - not quite as awful as Nevada's - but it's getting unstuck. It's made nasty cuts to close ugly deficits, but it hasn't had to release prisoners or close parks, and its IOUs are being paid. Its businesses aren't fleeing to Nevada or anywhere else; Jed Kolko, an economist at the Public Policy Institute of California, has shown that fewer than one-tenth of 1% of its jobs leave the state each year. Even California's real problems tend to get magnified by its size. If it were...
...icebreaker. It's even an icebreaker now in many ways. I was on an airplane coming back from Europe two days ago, and I didn't have on a pin because it doesn't work with security. And people would come up and say, "Why aren't you wearing a pin today?" So it's kind of become a thing. And I love to have people come up to talk to me, so it makes it more conversational and approachable...
Attorney Richard O'Brien, who is representing Northwestern in the case, says any idea that the school's student journalists aren't entitled to the same protections as working reporters is flawed. "It's not as traditional a platform as the New York Times or the Chicago Tribune, but I don't think anyone pretends that online journalism isn't journalism these days," O'Brien says. A judge is scheduled to hear arguments on the subpoena...
...biologics companies are still years away from seeing their first profits in this high-risk, high-return business. Their trade association, BIO, says that in the past 11 months, at least 40 of them have cut back or eliminated drug-development programs. The venture capitalists who invest in them "aren't looking to cure Parkinson's disease as much as they are looking for a return on their investments," says Greenwood. "They're just as happy to put their money into the next iPod." But increasingly, the big players in the pharmaceutical industry are moving into the biologics business themselves...